Clinical trials
Gingival Recession trials in the United States with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
32 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 4 |
| 2019 | 3 |
| 2020 | 3 |
| 2021 | 3 |
| 2023 | 5 |
| 2024 | 1 |
| 2025 | 2 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 16 |
| Not yet recruiting | 4 |
| Recruiting | 4 |
| Withdrawn | 3 |
| Enrolling by invitation | 2 |
| Terminated | 1 |
| Unknown status | 1 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University of Alabama at Birmingham | 5 |
| University of Michigan | 4 |
| University of Louisville | 3 |
| Mauro Santamaria | 2 |
| The University of Texas Health Science Center at San Antonio | 2 |
| American Academy of Facial Esthetics | 1 |
| Case Western Reserve University | 1 |
| Geistlich Pharma AG | 1 |
| Hailey Bivens | 1 |
| Harvard Medical School (HMS and HSDM) | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Gingival Recession | 32 |
| Dentin Sensitivity | 2 |
| Diabetes Mellitus | 2 |
| Bicuspid Aortic Valve Disease | 1 |
| Bone Diseases, Metabolic | 1 |
| Gingival Diseases | 1 |
| Pain | 1 |
| Periodontal Diseases | 1 |
| Postoperative Pain | 1 |
| Wounds and Injuries | 1 |
Trials
Showing 1 to 25 of 32. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.